Exercise augments the modulatory effects of vitamin E on pre-diabetes-induced aortopathy: a potential role of adiponectin

References

• Achari, A.E. and Jain, S.K., 2017. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. International journal of molecular sciences, 18 (6). doi:10.3390/ijms18061321
   PubMed Web of Science ®Google Scholar
• Aragno, M., et al., 2009. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free radical biology & medicine, 47 (7), 1067–1074.
   PubMed Web of Science ®Google Scholar
• Barazzoni, R., et al., 2012. Adipokines, ghrelin and obesity-associated insulin resistance in nondiabetic patients with acute coronary syndrome. Obesity, 20 (12), 2348–2353.
   PubMed Web of Science ®Google Scholar
• Boa, B.C., et al., 2014. Chronic aerobic exercise associated to dietary modification improve endothelial function and eNOS expression in high fat fed hamsters. PLoS one, 9 (10), e111158.
   Web of Science ®Google Scholar
• Booth, S.L., et al., 2004. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. The American journal of clinical nutrition, 80 (1), 143–148.
   PubMed Web of Science ®Google Scholar
• Campos, R., et al., 2018. Relationship between adiponectin and leptin on osteocalcin in obese adolescents during weight loss therapy. Archives of endocrinology and metabolism, 62 (3), 275–284.
   PubMed Web of Science ®Google Scholar
• Dallak, M.A., et al., 2018. Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. Ultrastructural pathology, 42 (2), 155–161.
   PubMed Web of Science ®Google Scholar
• Eckel, R.H., Grundy, S.M., and Zimmet, P.Z., 2005. The metabolic syndrome. Lancet (London, England), 365 (9468), 1415–1428.
   PubMed Web of Science ®Google Scholar
• Etchegoyen, M., et al., 2018. Metabolic syndrome and neuroprotection. Frontiers in neuroscience, 12, 196–200.
   PubMed Web of Science ®Google Scholar
• Grattagliano, I., et al., 2008. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. The Journal of nutritional biochemistry, 19 (8), 491–504.
   PubMed Web of Science ®Google Scholar
• Khan, U.I., et al., 2012. Race-ethnic differences in adipokine levels: the Study of Women’s Health Across the Nation (SWAN). Metabolism: clinical and experimental, 61 (9), 1261–1269.
   PubMed Web of Science ®Google Scholar
• Kopelman, P.G., 2000. Obesity as a medical problem. Nature, 404 (6778), 635–643.
   PubMed Web of Science ®Google Scholar
• Li, C.J., et al., 2007. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. The journal of endocrinology, 193 (1), 137–145.
   PubMed Web of Science ®Google Scholar
• Li, H., et al., 2011. Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study. Chinese medical journal, 124, 3607–3612.
   PubMed Web of Science ®Google Scholar
• Lim, H.S., et al., 2005. Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity. Heart, 91 (12), 1605–1606.
   PubMed Web of Science ®Google Scholar
• Lindsay, R.S., et al., 2002. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (London, England), 360 (9326), 57–58.
   PubMed Web of Science ®Google Scholar
• Liu, Q., et al., 2012. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proceedings of the National Academy of Sciences of the United States of America, 109 (36), 14568–14573.
   PubMed Web of Science ®Google Scholar
• Lustig, R.H., Schmidt, L.A., and Brindis, C.D., 2012. Public health: the toxic truth about sugar. Nature, 482 (7383), 27–29.
   PubMed Web of Science ®Google Scholar
• Lv, J.X., Kong, Q., and Ma, X., 2017. Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases. Chronic diseases and translational medicine, 3, 207–212.
   PubMedGoogle Scholar
• Matthews, D.R., et al., 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28 (7), 412–419.
   PubMed Web of Science ®Google Scholar
• Nacci, C., et al., 2013. Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity. The journal of clinical endocrinology and metabolism, 98, 2012–4119.
   Web of Science ®Google Scholar
• Nseir, W., et al., 2011. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Digestive diseases and sciences, 56 (12), 3439–3449.
   PubMed Web of Science ®Google Scholar
• Qin, F., et al., 2003. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. Journal of vascular surgery, 37 (2), 433–439.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei, M., et al., 2014. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine, 5 (8), 927–946.
   PubMedGoogle Scholar
• Ramanathan, N., et al., 2018. Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities. Nutrition and metabolism, 15, 018–0244.
   Google Scholar
• Rocha, R.E., et al., 2013. Interval training attenuates the metabolic disturbances in type 1 diabetes rat model. Arquivos Brasileiros de endocrinologia & metabologia, 57 (8), 594–602.
   PubMedGoogle Scholar
• Ronti, T., Lupattelli, G., and Mannarino, E., 2006. The endocrine function of adipose tissue: an update. Clinical endocrinology, 64 (4), 355–365.
   PubMed Web of Science ®Google Scholar
• Sena, C.M., et al., 2017. Adiponectin improves endothelial function in mesenteric arteries of rats fed a high-fat diet: role of perivascular adipose tissue. British journal of pharmacology, 174 (20), 3514–3526.
   PubMed Web of Science ®Google Scholar
• Shibata, R., et al., 2017. The role of adipokines in cardiovascular disease. Journal of cardiology, 70 (4), 329–334.
   PubMed Web of Science ®Google Scholar
• Shimabukuro, M., et al., 2003. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. The journal of clinical endocrinology and metabolism, 88 (7), 3236–3240.
   PubMed Web of Science ®Google Scholar
• Sonneveld, M.A., et al., 2015. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thrombosis and haemostasis, 113 (3), 577–584.
   PubMed Web of Science ®Google Scholar
• Spranger, J., et al., 2003. Adiponectin and protection against type 2 diabetes mellitus. Lancet (London, England), 361 (9353), 226–228.
   PubMed Web of Science ®Google Scholar
• Vargas-Robles, H., et al., 2015. Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice. Oxidative medicine and cellular longevity, 2015, 467471.
   PubMed Web of Science ®Google Scholar
• Yoshimura, N., et al., 2011. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. The journal of rheumatology, 38 (5), 921–930.
   PubMed Web of Science ®Google Scholar